Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar more
Time Frame | TMO | Sector | S&P500 |
---|---|---|---|
1-Week Return | -0.54% | -2.12% | -3% |
1-Month Return | 2.19% | -3.42% | -0.73% |
3-Month Return | -14.61% | -11.13% | 2.87% |
6-Month Return | -5.95% | -5.74% | 7.17% |
1-Year Return | 0.89% | 3.97% | 25.31% |
3-Year Return | -19.29% | 1.05% | 28.38% |
5-Year Return | 60.4% | 34.37% | 81.89% |
10-Year Return | 306.46% | 97.88% | 183.27% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 25.54B | 32.22B | 39.21B | 44.91B | 42.86B | [{"date":"2019-12-31","value":56.87,"profit":true},{"date":"2020-12-31","value":71.73,"profit":true},{"date":"2021-12-31","value":87.3,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":95.42,"profit":true}] |
Cost of Revenue | 13.71B | 15.71B | 18.98B | 25.41B | 25.30B | [{"date":"2019-12-31","value":53.96,"profit":true},{"date":"2020-12-31","value":61.83,"profit":true},{"date":"2021-12-31","value":74.67,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":99.53,"profit":true}] |
Gross Profit | 11.83B | 16.50B | 20.23B | 19.50B | 17.56B | [{"date":"2019-12-31","value":58.45,"profit":true},{"date":"2020-12-31","value":81.57,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":96.37,"profit":true},{"date":"2023-12-31","value":86.79,"profit":true}] |
Gross Margin | 46.30% | 51.23% | 51.60% | 43.42% | 40.98% | [{"date":"2019-12-31","value":89.73,"profit":true},{"date":"2020-12-31","value":99.28,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":84.13,"profit":true},{"date":"2023-12-31","value":79.41,"profit":true}] |
Operating Expenses | 7.65B | 8.61B | 10.01B | 10.99B | 10.70B | [{"date":"2019-12-31","value":69.55,"profit":true},{"date":"2020-12-31","value":78.34,"profit":true},{"date":"2021-12-31","value":91.05,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":97.36,"profit":true}] |
Operating Income | 4.59B | 7.79B | 10.03B | 8.39B | 6.86B | [{"date":"2019-12-31","value":45.81,"profit":true},{"date":"2020-12-31","value":77.72,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":83.7,"profit":true},{"date":"2023-12-31","value":68.4,"profit":true}] |
Total Non-Operating Income/Expense | (976.00M) | (1.05B) | (1.68B) | (1.01B) | (1.09B) | [{"date":"2019-12-31","value":-97600000000,"profit":false},{"date":"2020-12-31","value":-105500000000,"profit":false},{"date":"2021-12-31","value":-168000000000,"profit":false},{"date":"2022-12-31","value":-101200000000,"profit":false},{"date":"2023-12-31","value":-109500000000,"profit":false}] |
Pre-Tax Income | 4.07B | 7.22B | 8.84B | 7.83B | 6.30B | [{"date":"2019-12-31","value":46.04,"profit":true},{"date":"2020-12-31","value":81.72,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":88.62,"profit":true},{"date":"2023-12-31","value":71.24,"profit":true}] |
Income Taxes | 374.00M | 850.00M | 1.11B | 703.00M | (284.00M) | [{"date":"2019-12-31","value":33.72,"profit":true},{"date":"2020-12-31","value":76.65,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":63.39,"profit":true},{"date":"2023-12-31","value":-25.61,"profit":false}] |
Income After Taxes | 3.70B | 6.38B | 7.73B | 7.13B | 6.58B | [{"date":"2019-12-31","value":47.8,"profit":true},{"date":"2020-12-31","value":82.45,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":92.24,"profit":true},{"date":"2023-12-31","value":85.13,"profit":true}] |
Income From Continuous Operations | 3.70B | 6.38B | 7.73B | 6.96B | 5.92B | [{"date":"2019-12-31","value":47.83,"profit":true},{"date":"2020-12-31","value":82.49,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":90.06,"profit":true},{"date":"2023-12-31","value":76.64,"profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 3.70B | 6.38B | 7.72B | 6.95B | 6.00B | [{"date":"2019-12-31","value":47.84,"profit":true},{"date":"2020-12-31","value":82.52,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":89.97,"profit":true},{"date":"2023-12-31","value":77.61,"profit":true}] |
EPS (Diluted) | 12.34 | 19.55 | 25.11 | 23.24 | 21.54 | [{"date":"2019-12-31","value":49.14,"profit":true},{"date":"2020-12-31","value":77.86,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":92.55,"profit":true},{"date":"2023-12-31","value":85.78,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
TMO | |
---|---|
Cash Ratio | 0.46 |
Current Ratio | 1.63 |
Quick Ratio | 1.26 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
TMO | |
---|---|
ROA (LTM) | 4.67% |
ROE (LTM) | 12.94% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
TMO | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.51 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.49 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
TMO | |
---|---|
Trailing PE | 32.35 |
Forward PE | 21.83 |
P/S (TTM) | 4.66 |
P/B | 4.03 |
Price/FCF | 104 |
EV/R | 5.34 |
EV/Ebitda | 19.65 |
PEG | 1.97 |
Thermo Fisher Scientific Inc (TMO) share price today is $524.05
Yes, Indians can buy shares of Thermo Fisher Scientific Inc (TMO) on Vested. To buy Thermo Fisher Scientific Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TMO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Thermo Fisher Scientific Inc (TMO) via the Vested app. You can start investing in Thermo Fisher Scientific Inc (TMO) with a minimum investment of $1.
You can invest in shares of Thermo Fisher Scientific Inc (TMO) via Vested in three simple steps:
The 52-week high price of Thermo Fisher Scientific Inc (TMO) is $627.02. The 52-week low price of Thermo Fisher Scientific Inc (TMO) is $492.93.
The price-to-earnings (P/E) ratio of Thermo Fisher Scientific Inc (TMO) is 32.3538
The price-to-book (P/B) ratio of Thermo Fisher Scientific Inc (TMO) is 4.03
The dividend yield of Thermo Fisher Scientific Inc (TMO) is 0.3%
The market capitalization of Thermo Fisher Scientific Inc (TMO) is $197.63B
The stock symbol (or ticker) of Thermo Fisher Scientific Inc is TMO